NGM Biopharmaceuticals, Inc.

NGM · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$58,815$73,456$151,795$147,017
Short-Term Investments$88,369$198,036$214,458$148,139
Receivables$58$7,580$4,945$6,433
Inventory$0$0$0$0
Other Curr. Assets$9,202$9,787$8,082$6,837
Total Curr. Assets$156,444$288,859$379,280$308,426
Property Plant & Equip (Net)$7,033$10,592$14,116$14,526
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,455$3,954$1,499$1,499
Tax Assets$0$0$0$0
Other NC Assets$2,936$3,997$7,492$4,592
Total NC Assets$12,424$18,543$23,107$20,617
Other Assets$0$0$0$0
Total Assets$168,868$307,402$402,387$329,043
Liabilities
Payables$2,982$8,453$5,246$9,663
Short-Term Debt$0$5,385$5,077$0
Tax Payable$0$0$0$0
Deferred Revenue$0$366$17,774$0
Other Curr. Liab.$17,099$33,638$33,258$32,920
Total Curr. Liab.$20,081$47,842$61,355$42,583
LT Debt$0$0$5,385$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$149$0$0$6,417
Total NC Liab.$149$14,204$5,385$6,417
Other Liabilities$0-$14,204$0$0
Cap. Leases$0$0$0$0
Total Liabilities$20,230$47,842$66,740$49,000
Equity
Pref Stock$0$0$0$0
Common Stock$83$82$78$71
Retained Earnings-$724,008-$581,633-$418,966-$298,631
AOCI$18-$302-$129$4
Other Equity$872,545$841,413$754,664$578,599
Total Equity$148,638$259,560$335,647$280,043
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$168,868$307,402$402,387$329,043
Net Debt-$58,815-$68,071-$141,333-$147,017